activ ity. Arterioscler Thromb.

;

:

-

Fowkes FGR, Connor JM, Smith FB, Wood J, Donnan PT, GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet.

;

:

-

Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney Cambien F. The

G/

G genetic polymorphism in the promoter of the plasminogen activator inhibitor

(PAI-

) gene is associated with dif ferences in plasma PAI-

activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost.

;

:

-

Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology exceptional individuals: the lesson of centenarians. Immunol Today.

;

:

-

Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful ageing. Blood.

;

:

-

Mari D, Mannucci PM, Duca F, Bertolini S, Franceschi C. Mutant fac tor V (Arg

Gln) in healthy centenarians. Lancet.

;

:

Lighart GJ, Corberand JX, Fournier C, Galanand P, Higmans W, Kennes B, Muller O, Hermelik HK, Stinmann GC. Admission crite ria for immunogerontological studies in man: the Senieur Protocol. Mech Ageing Dev.

;

:

-

Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human mutated cells. Nucleic Acid Res.

;

:

-

Thomas A, Green F, Kelleher C; Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promotor region of the (

fib rinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost.

;

:

-

Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb.

,

:

-

Dawson S, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-

(PAI-

) gene responds differently to IL-

in Hep G

cells. / Biol Chem.

;

:

-

Roff DA, Bentzen P. The statistical analysis of mitochondrial DNA polymorphisms: chi square and the problem of small samples. Mol Bio

vol.

;

:

-

Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet.

;

:

-

Mansfield MW, Stickland MH, Grant PJ. Environmental and genetic factors in relation to elevated circulating levels of plasminogen acti vator inhibitor-

in Caucasian patients with non-insulin dependent diabetes mellitus. Thromb Haemost.

;

:

-

Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Laseur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet.

;

:

-

Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard SM, Bara L, Ricard S, Tiret L, Amougel P, Alhenc- Gelas F, Soubrier E. Deletion polymorphism in the gene coding for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature.

;

:

-

Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amougel P, Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental his tory of myocardial infarction. Lancet.

;

:

-

Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis.

;

:

-

Van Boekmeer FM, Mamotte CDS. Apolipoprotein e

homozygos ity in young men with coronary heart disease. Lancet.

;

:

-